Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Blaisdell

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Inflammatory Bowel Diseases|March 29, 2022
Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In VitroAdam Blaisdell, Yan Zhou, Michael G Kattah, et al.
The Journal of Clinical Investigation|October 11, 2019
Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophilsKarim Mahiddine, Adam Blaisdell, Stephany Ma, et al.
Cancer Cell|December 19, 2015
Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor CellsAdam Blaisdell, Amandine Crequer, Devin Columbus, et al.
Plos One|August 6, 2009
Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage proteaseZuben E Sauna, Chinyere Okunji, Ryan C Hunt, et al.
Thrombosis and Haemostasis|July 29, 2010
A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissuesNoam Shomron, Nobuko Hamasaki-Katagiri, Ryan Hunt, et al.
The Journal of Biological Chemistry|November 13, 2012
Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat)Klilah Hershko, Vijaya L Simhadri, Adam Blaisdell, et al.
Plos One|July 7, 2012
Characterization of coding synonymous and non-synonymous variants in ADAMTS13 using ex vivo and in silico approachesNathan C Edwards, Zachary A Hing, Avital Perry, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Base-editing a single missense mutation in A20 enhances CAR-T cell efficacyAdam Blaisdell, Stefanie Bachl, Luis R Sandoval, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Inflammatory Bowel Diseases|March 29, 2022
Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In VitroAdam Blaisdell, Yan Zhou, Michael G Kattah, et al.
The Journal of Clinical Investigation|October 11, 2019
Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophilsKarim Mahiddine, Adam Blaisdell, Stephany Ma, et al.
Cancer Cell|December 19, 2015
Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor CellsAdam Blaisdell, Amandine Crequer, Devin Columbus, et al.
Plos One|August 6, 2009
Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage proteaseZuben E Sauna, Chinyere Okunji, Ryan C Hunt, et al.
Thrombosis and Haemostasis|July 29, 2010
A splice variant of ADAMTS13 is expressed in human hepatic stellate cells and cancerous tissuesNoam Shomron, Nobuko Hamasaki-Katagiri, Ryan Hunt, et al.
The Journal of Biological Chemistry|November 13, 2012
Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat)Klilah Hershko, Vijaya L Simhadri, Adam Blaisdell, et al.
Plos One|July 7, 2012
Characterization of coding synonymous and non-synonymous variants in ADAMTS13 using ex vivo and in silico approachesNathan C Edwards, Zachary A Hing, Avital Perry, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Base-editing a single missense mutation in A20 enhances CAR-T cell efficacyAdam Blaisdell, Stefanie Bachl, Luis R Sandoval, et al.
Pageof 1